Results 71 to 80 of about 50,593 (147)

Cardiac Myosin Inhibitors in Hypertrophic Cardiomyopathy: Clinical Advances and Therapeutic Prospects. [PDF]

Drug Des Devel Ther
Hou L, Lin B, Ji X, Huang A.
europepmc   +1 more source

Incidence of Ventricular Arrhythmias and Sudden Cardiac Death with Cardiac Myosin Inhibitors in Hypertrophic Cardiomyopathy: A Meta-Analysis of Randomized Controlled Trials. [PDF]

J Pers Med
Katic J, Bulum T, Borovac JA.
europepmc   +1 more source

Effects of myosin inhibitors on the X-ray diffraction patterns of relaxed and calcium-activated rabbit skeletal muscle fibers. [PDF]

Biophys Physicobiol, 2018
Iwamoto H.
europepmc   +1 more source

Effect of Cardiac Myosin Inhibitors on Echocardiographic Features of Cardiac Structure and Function in Hypertrophic Cardiomyopathy: A Systematic Review and Meta-Analysis. [PDF]

Rev Cardiovasc Med
Lu Y, Zhu Y, Tian Z.
europepmc   +1 more source

Cardiac myosin inhibitors - a cutting-edge solution for the management of hypertrophic cardiomyopathy: a narrative review. [PDF]

Ann Med Surg (Lond)
Younas A, Qadri M, Ijlal A, Khan T, Pirzada L, Kumari V, Mubbashir A, Singh PK, Sherwani MRK, Noor R, Nausheen F, Ahmad B, Rahim H, Akilimali A.   +13 more
europepmc   +1 more source

Inhibitor of myosin light chain kinase.

Japanese Journal of Pharmacology, 1993
openaire   +1 more source

Small Molecules to Treat Cardiovascular Disease: Cardiac Myosin Inhibitors

Cardiovascular Innovations and Applications
Lisa D. Wilsbacher
doaj   +1 more source

Cardiac myosin inhibitors: Efficacy, safety and future directions of aficamten in hypertrophic obstructive cardiomyopathy. [PDF]

Egypt Heart J
Ogieuhi IJ, Ajekiigbe VO, Adeyemi BA, Nwatamole B, Ayodeji KB, Ugiomoh OM, Odeniyi TA, Akingbola A, Iyawe EP, Oladejo OO, Lawal MO, Woldehana NA, Bakare IS, Patience AT, Okoro GC.   +14 more
europepmc   +1 more source

Cardiac myosin inhibitors for hypertrophic cardiomyopathy: a systematic review and meta-analysis of randomized controlled trials. [PDF]

Ann Med Surg (Lond)
Hasana U, Korpal M, Haider F, Umer M, Lwin NPT, Iqbal S, Kumar R, Ahsan M, Hassan E, Ullah W, Khalid S, Gupta A, Alsubari AMA, Ehsan M, Ahmad A.   +14 more
europepmc   +1 more source

The clinical utility of cardiac myosin inhibitors for the management of hypertrophic cardiomyopathy: a scoping review. [PDF]

Heart Fail Rev
Othman L, Koskina L, Huerta N, Rao SJ.
europepmc   +1 more source